Current and potential use of MAINTRAC method for cancer diagnosis and prediction of metastasis

References

• Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133(2):275-88
   PubMed Web of Science ®Google Scholar
• Moldenhauer G, Momburg F, Möller P, et al. Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer 1987;56:714-21
   PubMed Web of Science ®Google Scholar
• Zhou L, Somasundaram R, Nederhof RF, et al. Impact of human granulocyte and monocyte isolation procedures on functional studies. Clin Vaccine Immunol 2012;19:1065-74
   PubMed Web of Science ®Google Scholar
• Mehrishi JN, Bakács T. A novel method of CD34+ cell separation from umbilical cord blood. Transfusion 2013;53:2675-80
   PubMed Web of Science ®Google Scholar
• Pachmann K, Camara O, Kroll T, et al. Efficacy control of therapy using circulating epithelial tumor cells (CETC) as ‘Liquid Biopsy’: trastuzumab in HER2/neu-Positive Breast Carcinoma. J Cancer Res Clin Oncol 2011;137:1317-27
   PubMed Web of Science ®Google Scholar
• Pachmann K, Clement JH, Schneider CP, et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med 2005;43:617-27
   PubMed Web of Science ®Google Scholar
• Pachmann U A, Hekimian K, Carl S, et al. Comparing sequential steps for detection of circulating tumor cells: more specific or just less sensitive? Webmed Central CANCER 2011;2(2):WMC001490
   Google Scholar
• Pizon M, Zimon D, Carl S, et al. Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer. Ecancermedicalscience 2013;7:343
   PubMedGoogle Scholar
• Camara O, Rengsberger M, Egbe A, et al. The Relevance of Circulating Epithelial Tumour Cells (CETC) for Therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. Ann Oncol 2007;18:1484-92
   PubMed Web of Science ®Google Scholar
• Retsky MW, Hrushesky WJ, Gukas ID. Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer. BMC Cancer 2009;9:7
   PubMed Web of Science ®Google Scholar
• Neeman E, Ben-Eliyahu S. Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav Immun 2013(30 Suppl):S32-40
   Google Scholar
• Tavare AN, Perry NJ, Benzonana LL, et al. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer 2012;130:1237-50
   PubMed Web of Science ®Google Scholar
• Retsky M, Demicheli R, Hrushesky WJM, et al. Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new Findings and a Review. Curr Med Chem 2013;20:4163-76
   PubMed Web of Science ®Google Scholar
• Rolle A, Günzel R, Pachmann U, et al. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitoring by MAINTRAC is a predictor for relapse: a preliminary report. World J Surg Oncology 2005;3:18
   PubMedGoogle Scholar
• Camara O, Kavallaris A, Nöschel H, et al. Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells. World J Surg Oncol 2006;4:67
   PubMedGoogle Scholar
• Schöne U, Überrück T, Altendorf-Hofmann A, et al. Evaluation of circulating tumour cells in peripheral blood samples of patients with colorectal carcinoma using MAINTRAC® 131. Kongress Deutsche Gesellschaft für Chirurgie, Berlin Germany; 25–28 March 2014 ( Abstract-ID:545)
   Google Scholar
• Segatto I, Berton S, Sonego M, et al. Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling. Oncotarget 2014;5:6267-79
   PubMedGoogle Scholar
• Fisher B. Laboratory and clinical research in breast cancer: a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res 1980;40:3863-74
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Valagussa P, Veronesi U. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. J Clin Oncol 2008;26:342-4
   PubMed Web of Science ®Google Scholar
• De Laurentiis M, Cancello G, D’Agostino D, et al. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials. Clin Oncol 2008;26:44-53
   Web of Science ®Google Scholar
• Schmidt M. Chemotherapy in early breast cancer: when, how and which one? Breast Care 2014;9:154-60
   PubMed Web of Science ®Google Scholar
• Pachmann K, Camara O, Kavallaris A, et al. Monitoring the Response of Circulating Epithelial Tumor Cells (CETC) to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol 2008;26:1208-15
   PubMed Web of Science ®Google Scholar
• Rüdiger N, Stein EL, Schill E, et al. Chemosensitivity Testing of Circulating Epithelial Tumor Cells (CETC) in Vitro: Correlation to in Vivo Sensitivity and Clinical Outcome. J Cancer Therapy 2013;4:597-605
   Google Scholar
• Smerage JB, Barlow WE, Hortobagyi GN. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. J Clin Oncol 2014;32:3483-9
   PubMed Web of Science ®Google Scholar
• Naume B, Synnestvedt M, Falk RS, et al. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer. J Clin Oncol 2014;32(34):3848-57
   PubMed Web of Science ®Google Scholar
• Pachmann K, Camara O, Kohlhase A, et al. Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC:): the example of SERM therapy monitoring as a unique tool to individualize therapy. J Cancer Res Clin Oncol 2011;137:821-8
   PubMed Web of Science ®Google Scholar